{
    "organizations": [],
    "uuid": "52b26ef06819dd40712394e3dc503755cfbab2c3",
    "author": "",
    "url": "https://www.reuters.com/article/brief-janssen-announces-fda-breakthrough/brief-janssen-announces-fda-breakthrough-therapy-designation-for-erdafitinib-in-the-treatment-of-metastatic-urothelial-cancer-idUSASC09SF3",
    "ord_in_thread": 0,
    "title": "BRIEF-Janssen Announces FDA Breakthrough Therapy Designation For Erdafitinib In The Treatment Of Metastatic Urothelial Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 26 PM / Updated 20 minutes ago BRIEF-Janssen Announces FDA Breakthrough Therapy Designation For Erdafitinib In The Treatment Of Metastatic Urothelial Cancer Reuters Staff 1 Min Read   Johnson & Johnson: * JANSSEN ANNOUNCES U.S. FDA BREAKTHROUGH THERAPY DESIGNATION FOR ERDAFITINIB IN THE TREATMENT OF METASTATIC UROTHELIAL CANCER * JANSSEN PHARMACEUTICAL - BREAKTHROUGH THERAPY DESIGNATION BASED ON DATA FROM MULTICENTER, OPEN-LABEL PHASE 2 CLINICAL TRIAL OF ERDAFITINIB Source text for Eikon:  ",
    "published": "2018-03-15T14:24:00.000+02:00",
    "crawled": "2018-03-15T14:42:09.025+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "fda",
        "breakthrough",
        "therapy",
        "designation",
        "erdafitinib",
        "treatment",
        "metastatic",
        "urothelial",
        "cancer",
        "reuters",
        "staff",
        "min",
        "read",
        "johnson",
        "johnson",
        "janssen",
        "announces",
        "fda",
        "breakthrough",
        "therapy",
        "designation",
        "erdafitinib",
        "treatment",
        "metastatic",
        "urothelial",
        "cancer",
        "janssen",
        "pharmaceutical",
        "breakthrough",
        "therapy",
        "designation",
        "based",
        "data",
        "multicenter",
        "phase",
        "clinical",
        "trial",
        "erdafitinib",
        "source",
        "text",
        "eikon"
    ]
}